Search

Reckitt Benckiser Group PLC

Closed

Sector Finance

5,266 -0.42

Overview

Share price change

24h

Current

Min

5264

Max

5280

Key metrics

By Trading Economics

Income

1.1B

Sales

7.2B

P/E

Sector Avg

24.544

26.698

Dividend yield

3.68

Profit margin

15.934

Employees

40,000

EBITDA

1.9B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+5.21 upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

3.68%

3.82%

Next Earnings

6 Mar 2025

Market Stats

By TradingEconomics

Market Cap

-1.2B

36B

Previous open

5266.42

Previous close

5266

News Sentiment

By Acuity

36%

64%

151 / 545 Finance

Reckitt Benckiser Group PLC Chart

Past performance is not a reliable indicator of future results.

Related News

1 Nov 2024, 14:15 UTC

Major Market Movers

Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win -- Update

1 Nov 2024, 10:10 UTC

Major Market Movers

Reckitt Shares Surge After Baby Formula Lawsuit Win

31 Oct 2024, 23:14 UTC

Major Market Movers

Abbott Laboratories Shares Rise After Baby-Formula Verdict

23 Oct 2024, 11:27 UTC

Major Market Movers

Correction to Reckitt Benckiser 2nd Update

23 Oct 2024, 10:26 UTC

Major Market Movers

Lysol Maker Reckitt Benckiser Beats Views as Easing Prices Draw Shoppers -- 2nd Update

23 Oct 2024, 07:47 UTC

Earnings

Lysol Maker Reckitt Benckiser Sales Beat Expectations as Volume Declines Ease -- Update

18 Sept 2024, 09:02 UTC

Acquisitions, Mergers, Takeovers

Reckitt Begins Talks for $7.9 Billion Disposal of Homecare Assets, Bloomberg Reports

29 Jul 2024, 09:27 UTC

Major Market Movers

Reckitt Benckiser Shares Tumble on Abbott's Baby-Formula Litigation

24 Jul 2024, 08:29 UTC

Earnings

Reckitt to Sell Some Home-Care Brands, Review Infant Formula Unit in Shake-Up -- Update

4 Feb 2025, 10:08 UTC

Market Talk
Earnings

Reckitt Benckiser's Portfolio Reshaping Brings Greater Risks -- Market Talk

13 Nov 2024, 11:00 UTC

Market Talk

Reckitt Is Most Exposed in European Consumer Goods to Potential U.S. Tariff, UBS Says -- Market Talk

23 Oct 2024, 07:50 UTC

Market Talk
Earnings

Reckitt Benckiser's Health, Nutrition Business Drive Sales Beat -- Market Talk

23 Oct 2024, 06:07 UTC

Earnings

Reckitt Benckiser: US Nutrition Sales Dragged by Mount Vernon Tornado in July

23 Oct 2024, 06:05 UTC

Earnings

Reckitt Benckiser 3Q Nutrition LFL Rev Down 17.4%

23 Oct 2024, 06:05 UTC

Earnings

Reckitt Benckiser 3Q Health LFL Rev Up 3.2%

23 Oct 2024, 06:05 UTC

Earnings

Reckitt Benckiser 3Q Hygiene LFL Rev Up 2.1%

23 Oct 2024, 06:04 UTC

Earnings

Reckitt Benckiser 3Q Reported Revenue Down 4.0%

23 Oct 2024, 06:03 UTC

Earnings

Reckitt Benckiser: All Businesses Well Placed to Deliver Strong 4Q LFL Net Revenue Growth

23 Oct 2024, 06:03 UTC

Earnings

Analysts Saw Reckitt Benckiser 3Q Sales Volume Down 3.1%

23 Oct 2024, 06:03 UTC

Earnings

Reckitt Benckiser 3Q Sales Volume Down 1.4%

23 Oct 2024, 06:02 UTC

Earnings

Analysts Saw Reckitt Benckiser 3Q Price/Mix Up 1.4%

23 Oct 2024, 06:02 UTC

Earnings

Reckitt Benckiser 3Q Price/Mix Up 0.9%

23 Oct 2024, 06:01 UTC

Earnings

Analysts Saw Reckitt Benckiser 3Q LFL Revenue Down 1.7%

23 Oct 2024, 06:01 UTC

Earnings

Reckitt Benckiser 3Q LFL Revenue Down 0.5%

23 Oct 2024, 06:00 UTC

Earnings

Analysts Saw Reckitt Benckiser 3Q Rev at GBP3.41B

23 Oct 2024, 06:00 UTC

Earnings

Reckitt Benckiser 3Q Rev GBP3.455B

23 Oct 2024, 06:00 UTC

Earnings

Reckitt Benckiser Backs 2024 View

18 Sept 2024, 08:47 UTC

Acquisitions, Mergers, Takeovers

Reckitt Begins Talks for $7.9 Bln Disposal of Homecare Assets, Bloomberg Reports

24 Jul 2024, 11:56 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Reckitt Benckiser Could Look Appealing to Rivals Once Streamlined, Issues Addressed -- Market Talk

24 Jul 2024, 07:18 UTC

Market Talk
Earnings

Reckitt Portfolio Review Expected to Unlock Value -- Market Talk

Reckitt Benckiser Group PLC Forecast

Price Target

By TipRanks

5.21% upside

12 Months Forecast

Average 5,536 GBX  5.21%

High 7,700 GBX

Low 4,400 GBX

Based on 11 Wall Street analysts offering 12 month price targets forReckitt Benckiser Group PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

5

Buy

6

Hold

0

Sell

Sentiment

By Acuity

151 / 545 Finance

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Reckitt Benckiser Group PLC

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands. The company also offers home fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfecting sprays wipes, laundry sanitisers, and others; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands. In addition, it provides nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.